Skip to main content

Table 4 Factors associated with unfavourable outcomes 30 days after Enterococcus faecium bacteraemia (logistic regression)

From: Does vancomycin resistance increase mortality in Enterococcus faecium bacteraemia after orthotopic liver transplantation? A retrospective study

 UnivariateMultivariate
VariablesPatients with favourable outcome
n = 95
Patients with unfavourable outcome
n = 80
OR95% CIpOR95% CIp
Definitive infectious focus elimination
 Yes28 (29.5)17 (21.2)1.550.77–3.100.2171.920.79–4.660.150
 No67 (70.5)63 (78.8)      
Start of adequate AB Therapy within < 48 h post-BSI onset
 Yes48 (50.5)54 (67.5)2.031.10–3.770.02411.620.73–3.600.238
 No47 (49.5)26 (32.5)      
 Mean SOFANon-GCS (day-7 until day-1 before BSI onset)4.8 ± 3.810.8 ± 4.21.391.26–1.53< 0.0011.2%1.10–1.41< 0.001
 ICU stay between day-7 and BSI onset [days]3.7 ± 3.57.4 ± 1.81.551.34–1.78< 0.0011.241.03–1.490.023
Bacteraemia
 VRE19 (48.7)20 (51.3)1.330.65–2.720.4291.130.46–2.760.795
 VSE76 (55.9)60 (44.1)      
  1. Favourable outcome was defined as stay at home, on the ward or in a rehabilitation centre; unfavourable outcome was defined as death or ongoing need for ICU treatment.
  2. Data are presented as n (%) or mean ± standard deviation.
  3. *n = 175 (2 missing)
  4. Abbreviations: OR odds ratio, CI confidence interval, AB antibiotic therapy, BSI bloodstream infection, SOFA sequential organ failure assessment, GCS Glasgow coma scale, VRE vancomycin-resistant Enterococcus faecium, VSE vancomycin-susceptible Enterococcus faecium